Making healthcare big data & AI work for everyone, every day: Business Brunch in Zurich
“Making healthcare big data & AI work for everyone, every day” was held on November 21 2018 at Au Premier in Zürich, Switzerland. Presented by IQVIA, this invitation-only event focused on the impact of AI on the use of big data in healthcare. From the event description: “Accessing & working with big data can be cumbersome. Only a few people have the required skills and their time is often used up by data preparation. The most intricate analysis will always require expert data scientists, but with the right tools and training, even a non-expert can produce highly useful output. We will be discussing how to facilitate this transition.” Steve Scrace, Privacy Analytics’ Privacy Specialist for Europe, Middle East and Africa was there, and he provides this perspective:
What was The Big Idea?
“The attendees were really interested in how to advance their work on both big data and also on AI to support their work. What became apparent was their concern over getting access to the datasets they need, to make things happen. After clarifying the impact of GDPR regulations we were able to show how using a risk based determination approach to build anonymized data sets for secondary usage can allow companies to be both compliant but still maintain the usefulness of the data for the tasks in hand.”
Who was The Audience?
“The audience came from the healthcare industry, in particular pharmaceuticals and medical device organizations. Their goal was to learn more about how gathering data helps advance their analytics work and care, holistically. The questions of anonymization regarding imaging data, and data gathered across various devices, from the bedside to implants and wearables, are becoming increasingly complex.”
What value did Privacy Analytics bring to the event?
“Privacy Analytics, as an IQVIA company, is uniquely positioned to assist pharmaceutical and medical device companies looking to leverage big data and artificial intelligence. Given our experience in the health care space, and our organizations’ front-line engagement in the convergence of AI and medical devices, we can help these companies better understand the challenges they face; how to get the data they need to innovate; and share that data in a responsible way. Data anonymization, especially in the age of AI, is key to turning privacy into more than just potential, and achieving superior business results.”
As Privacy Solutions Manager for Europe, Middle East and Africa (EMEA), Steve Scrace engages with clients in these regions. Steve co-presented at the Chief Data and Analytics Officer Europe 2018 Conference in Frankfurt, Germany, with Andrew B. Lambert, Privacy Analytics’ Vice President Sales, Marketing and Business Development.
For more about Privacy Analytics and IQVIA:
Recommended reading: https://privacy-analytics.com/de-id-university/data-privacy-as-business-driver/
- Turn Data Assets into Business Opportunity Under CCPADecember 19, 2019
- How does risk-based anonymization work?December 18, 2019
- Why should I use Expert Determination over Safe Harbor?December 18, 2019
- What do I need to know about GDPR, HIPAA and CCPA to meet our regulatory and privacy obligations?December 18, 2019
- Should we invest in building our own de-identification capability?December 17, 2019
- GDPR and The Future of Clinical Trials Data SharingMarch 18, 2019
- Advancing Principled Data Practices in Support of Emerging TechnologiesMarch 15, 2019
- “Zero Risk Does Not Exist”February 7, 2019
- Is Anonymization Possible with Current Technologies?January 9, 2019
- Comparing the benefits of pseudonymisation and anonymisation under the GDPRDecember 20, 2018